“India has approved its first dengue vaccine, a two-dose vaccine from Takeda Pharmaceutical that, in a late-stage trial, was 80 percent effective against confirmed dengue during the year following the second shot,” reports The Doomslayer. The World Health Organization reported a record 14.4 million dengue cases and 11,201 deaths worldwide in 2024, including 232,425 cases and 233 deaths in India… Reported dengue cases in India rose 11-fold ​in the past two decades, according to Takeda Biopharmaceuticals India. Dengue fever is a tropical disease so painful it is also known as “breakbone fever.” In the U.S., the FDA approved one dengue fever vaccine called Dengvaxia in May 2019. Mosquitoes infested with Wolbachia bacteria have also been bred to fight dengue fever in Honduras, in hopes of replacing mosquitoes that spread dengue fever, with a strain of mosquitoes that doesn’t spread the disease.